1. Home
  2. PIPR vs LEGN Comparison

PIPR vs LEGN Comparison

Compare PIPR & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Piper Sandler Companies

PIPR

Piper Sandler Companies

N/A

Current Price

$289.63

Market Cap

5.8B

Sector

Finance

ML Signal

N/A

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

N/A

Current Price

$19.50

Market Cap

5.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PIPR
LEGN
Founded
1895
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.9B
IPO Year
2003
2020

Fundamental Metrics

Financial Performance
Metric
PIPR
LEGN
Price
$289.63
$19.50
Analyst Decision
Buy
Buy
Analyst Count
3
14
Target Price
$362.50
$63.46
AVG Volume (30 Days)
188.8K
2.0M
Earning Date
05-08-2026
01-01-0001
Dividend Yield
2.66%
N/A
EPS Growth
54.49
N/A
EPS
15.82
N/A
Revenue
$1,904,217,000.00
N/A
Revenue This Year
$13.09
$67.56
Revenue Next Year
$14.76
$43.20
P/E Ratio
$18.48
N/A
Revenue Growth
24.33
N/A
52 Week Low
$202.91
$16.24
52 Week High
$380.26
$45.30

Technical Indicators

Market Signals
Indicator
PIPR
LEGN
Relative Strength Index (RSI) 34.49 55.82
Support Level $248.90 $16.24
Resistance Level $341.25 $21.58
Average True Range (ATR) 11.60 0.91
MACD -1.56 0.20
Stochastic Oscillator 24.19 51.70

Price Performance

Historical Comparison
PIPR
LEGN

About PIPR Piper Sandler Companies

Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services followed by Equity financing.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: